Idioma:

Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage

Marongiu, Luigi ; Godi, Anna ; Parry, John V ; Beddows, Simon

BMC cancer, 2014-05, Vol.14 (1), p.384-384, Article 384 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por

Enviar para

Título:
Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage
Autor: Marongiu, Luigi ; Godi, Anna ; Parry, John V ; Beddows, Simon
Assuntos: Adult ; Cellular biology ; Cervical cancer ; CpG Islands - genetics ; Deoxyribonucleic acid ; DNA ; DNA methylation ; DNA Methylation - genetics ; Experiments ; Female ; Genetic testing ; Genomes ; Human papillomavirus ; Human papillomavirus 16 ; Human papillomavirus 16 - genetics ; Human papillomavirus 16 - pathogenicity ; Human papillomavirus 18 ; Human papillomavirus 18 - genetics ; Human papillomavirus 18 - pathogenicity ; Humans ; Infections ; Medical research ; Medical screening ; Middle Aged ; Public health ; Studies ; Uterine Cervical Neoplasms - genetics ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - virology ; Viral Load - genetics ; Virus Integration - genetics ; Womens health
É parte de: BMC cancer, 2014-05, Vol.14 (1), p.384-384, Article 384
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Descrição: Persistent infection with oncogenic Human Papillomavirus (HPV) is associated with the development of cervical cancer with each genotype differing in their relative contribution to the prevalence of cervical disease. HPV DNA testing offers improved sensitivity over cytology testing alone but is accompanied by a generally low specificity. Potential molecular markers of cervical disease include type-specific viral load (VL), integration of HPV DNA into the host genome and methylation of the HPV genome. The aim of this study was to evaluate the relationship between HPV type-specific viral load, integration and methylation status and cervical disease stage in samples harboring HPV16, HPV18, HPV31 or HPV45. Samples singly infected with HPV16 (n=226), HPV18 (n=32), HPV31 (n=75) or HPV45 (n=29) were selected from a cohort of 4,719 women attending cervical screening in England. Viral load and integration status were determined by real-time PCR while 3'L1-URR methylation status was determined by pyrosequencing or sequencing of multiple clones derived from each sample. Viral load could differentiate between normal and abnormal cytology with a sensitivity of 75% and a specificity of 80% (odds ratio [OR] 12.4, 95% CI 6.2-26.1; p<0.001) with some variation between genotypes. Viral integration was poorly associated with cervical disease. Few samples had fully integrated genomes and these could be found throughout the course of disease. Overall, integration status could distinguish between normal and abnormal cytology with a sensitivity of 72% and a specificity of 50% (OR 2.6, 95% CI 1.0-6.8; p=0.054). Methylation levels were able to differentiate normal and low grade cytology from high grade cytology with a sensitivity of 64% and a specificity of 82% (OR 8.2, 95% CI 3.8-18.0; p<0.001). However, methylation varied widely between genotypes with HPV18 and HPV45 exhibiting a broader degree and higher magnitude of methylated CpG sites than HPV16 and HPV31. This study lends support for HPV viral load and CpG methylation status, but not integration status, to be considered as potential biomarkers of cervical disease.
Editor: England: BioMed Central
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage

Marongiu, Luigi ; Godi, Anna ; Parry, John V ; Beddows, Simon

England: BioMed Central

Buscando em bases de dados remotas. Favor aguardar.